Taft attorney Joseph M. Bennett-Paris will speak at the UIA Conference “Brain Software, Genomics and Personalized Medicine: Legal and Biotechnology Challenges,” to be held May 15-16 in Minneapolis. His topic is "Biosimiliars Litigation: An Update."

Bennett-Paris is a partner in Taft’s Pharmaceutical and Life Sciences Litigation practice. He counsels clients in all areas of patent law, including patent prosecution, non-infringement, patentability, freedom-to-operate, invalidity and licensing. His practice primarily focuses on biotechnology, pharmaceutical, chemistry, and most recently, biosimilars.